Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000085447 | SCV001215910 | pathogenic | not provided | 2023-10-15 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 645 of the ABCA4 protein (p.Asp645Asn). This variant is present in population databases (rs61749418, gnomAD 0.004%). This missense change has been observed in individual(s) with Stargardt disease and retinitis pigmentosa (PMID: 9973280, 28559085, 29975949, 30029497, 31144483). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 99103). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function. For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001074983 | SCV001240592 | pathogenic | Retinal dystrophy | 2017-11-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000085447 | SCV001245786 | pathogenic | not provided | 2017-06-01 | criteria provided, single submitter | clinical testing | |
Retina International | RCV000085447 | SCV000117584 | not provided | not provided | no assertion provided | not provided |